BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35670043)

  • 21. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors.
    Valenti G; Quinn HM; Heynen GJJE; Lan L; Holland JD; Vogel R; Wulf-Goldenberg A; Birchmeier W
    Cancer Res; 2017 Apr; 77(8):2134-2147. PubMed ID: 28202523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
    Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
    BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluripotency transcription factors and cancer stem cells: small genes make a big difference.
    Liu A; Yu X; Liu S
    Chin J Cancer; 2013 Sep; 32(9):483-7. PubMed ID: 23419197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
    Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
    Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer stem cells and implications for future therapeutics.
    Wang J; Li ZH; White J; Zhang LB
    Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits.
    Li MM; Yuan J; Guan XY; Ma NF; Liu M
    Exp Hematol Oncol; 2021 Nov; 10(1):53. PubMed ID: 34774101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway.
    Li X; Meng Y; Xie C; Zhu J; Wang X; Li Y; Geng S; Wu J; Zhong C; Li M
    J Cell Biochem; 2018 May; 119(5):4134-4141. PubMed ID: 29243835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
    Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
    Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.